Expression of toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis

被引:206
作者
Iwahashi, M
Yamamura, M
Aita, T
Okamoto, A
Ueno, A
Ogawa, N
Akashi, S
Miyake, K
Godowski, PJ
Makino, F
机构
[1] Okayama Univ, Grad Sch Med & Dent, Dept Med & Clin Sci, Okayama 7008558, Japan
[2] Univ Tokyo, Tokyo, Japan
[3] Genentech Inc, San Francisco, CA 94080 USA
来源
ARTHRITIS AND RHEUMATISM | 2004年 / 50卷 / 05期
关键词
D O I
10.1002/art.20219
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. CD16 (IgG Fcgamma receptor type IIIA [FcgammaRIIIA])-expressing CD14+ monocytes express high levels of Toll-like receptor 2 (TLR-2) and are able to efficiently produce proinflammatory cytokines such as tumor necrosis factor alpha (TNFalpha). To understand the role of CD16 and TLR-2 in monocyte and macrophage activation in rheumatoid arthritis (RA), we investigated the expression of TLR-2 on CD16+ blood monocytes and synovial tissue macrophages and the effect of CD16 and TLR-2 activation on cytokine production. Methods. The expression of CD14, CDt6, TLR-2, and TLR-4 on blood monocytes was measured by flow cytometric analysis. CD16 and TLR-2 expression in RA synovial tissue was detected by 2-color immunofluorescence labeling. CD16+ mature monocytes were prepared by incubating blood monocytes in plastic plates for 24 hours. These adhered monocytes were stimulated with lipoteichoic acid (LTA), anti-FcgammaRIII antibody, and Hsp60 for 5 hours, and culture supernatants were measured for various cytokines by immunoassay. The activation of NF-kappaB was detected by electrophoretic mobility shift assay. Results. The frequency of CD16+ cells in all blood monocytes was significantly increased in patients with RA compared with healthy controls. TLR-2 was expressed at higher levels on CD16+ monocytes than on CD16- monocytes, while TLR-4 was expressed similarly on both monocytes. In IRA synovial tissue, CD16+/ TLR-2+ cells were distributed mainly in the lining layer. TLR-2 expression on monocytes was enhanced by macrophage colony-stimulating factor (M-CSF) and interleukin-10 (IL-10), but was reduced by transforming growth factor 131, while CE116 expression was inducible by these cytokines. Adhered monocytes (similar to50% CD16+) produced TNFalpha, IL-1beta, IL-6, IL-8, IL-12 p40, IL-1 receptor antagonist, and IL-10 after LTA stimulation. This cytokine response was inhibited significantly by anti-TLR-2 antibody and partly by anti-TLR-4 antibody. Anti-FcgammaRIII antibody stimulation markedly enhanced the LTA-induced TNFalpha response. Hsp60 could stimulate TNFa production by adhered monocytes, which was inhibited similarly by anti-TLR-2 antibody and anti-TLR-4 antibody. NF-kappaB activation in adhered monocytes was induced by LTA, but this NF-kappaB activity was not augmented by anti-Fc-/RIII antibody stimulation. Conclusion. These results suggest that CD16+ monocytes and synovial tissue macrophages with high TLR-2 expression may be induced by M-CSF and IL-10, and their production of TNFa could be simulated by endogenous TLR ligands such as Hsp60 and FcgammaRIIIA ligation by small immune complexes in RA joints.
引用
收藏
页码:1457 / 1467
页数:11
相关论文
共 37 条
  • [1] Abrahams VM, 2000, ARTHRITIS RHEUM-US, V43, P608, DOI 10.1002/1529-0131(200003)43:3<608::AID-ANR18>3.0.CO
  • [2] 2-G
  • [3] Toll-like receptors in the induction of the innate immune response
    Aderem, A
    Ulevitch, RJ
    [J]. NATURE, 2000, 406 (6797) : 782 - 787
  • [4] Toll-like receptors: critical proteins linking innate and acquired immunity
    Akira, S
    Takeda, K
    Kaisho, T
    [J]. NATURE IMMUNOLOGY, 2001, 2 (08) : 675 - 680
  • [5] ARNETT FC, 1987, ARTHRITIS RHEUM, V31, P315
  • [6] Baeten D, 2000, ARTHRITIS RHEUM, V43, P1233, DOI 10.1002/1529-0131(200006)43:6<1233::AID-ANR6>3.0.CO
  • [7] 2-9
  • [8] The NF-kappa B and I kappa B proteins: New discoveries and insights
    Baldwin, AS
    [J]. ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 : 649 - 683
  • [9] The proinflammatory CD14+CD16+DR++ monocytes are a major source of TNF
    Belge, KU
    Dayyani, F
    Horelt, A
    Siedlar, M
    Frankenberger, M
    Frankenberger, B
    Espevik, T
    Ziegler-Heitbrock, L
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (07) : 3536 - 3542
  • [10] ITAMs versus ITIMs: striking a balance during cell regulation
    Billadeau, DD
    Leibson, PJ
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (02) : 161 - 168